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Introduction
Normal cells only proliferate for a finite number of times until 
they become senescent (Hayflick, 1965), a state of irreversible 
proliferative arrest as a consequence of the genomic damage 
caused by telomere erosion (d’Adda di Fagagna et al., 2003). 
Senescence can also be induced prematurely as a result of a 
persistent DNA damage response (DDR) secondary to oxidative 
stress that induces double-strand breaks (DSBs; Campisi and 
d’Adda di Fagagna, 2007) or to DNA replication stress induced 
by oncogenes or drugs, which lead to DSB generation and DDR 
activation (Serrano et al., 1997; Bartkova et al., 2006; Di Micco 
et al., 2006). Cellular senescence not only plays a role in aging 
and contributes to the appearance of age-related pathologies 
(Vijg and Campisi, 2008; Baker et al., 2011) but is also an im-
portant antiproliferative process that acts as a strong barrier 
against cellular transformation and cancer progression (Collado 
and Serrano, 2010).
The actions of the thyroid hormones (THs) are mediated 
by binding to nuclear TH receptors (THRs) that are encoded 
by two genes: THRA and THRB (Aranda and Pascual, 2001). 
One of the most prominent actions of THs is the regulation of 
mitochondrial function (Oppenheimer et al., 1987). Mitochon-
dria are the major site of oxidative processes that lead to heat 
production and to generation of reactive oxygen species (ROS). 
Although it has been known for more than 100 yr that THs in-
crease basal metabolism (Magnus-Levy, 1895) and are major 
regulators of mitochondrial activity and oxygen consumption 
(Tata et al., 1962), the molecular mechanisms underlying these 
effects have not yet been fully defined.
THRs can also play a role in aging. Thus, hyperthyroidism 
accelerates aging (Ooka and Shinkai, 1986; Buffenstein and 
Pinto, 2009), whereas longevity is associated with decreased 
thyroid function (Atzmon et al., 2009; Rozing et al., 2010; 
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Figure 1. T3 induces cellular senescence and DNA damage. (A) 5 nM T3 increases the number of SA-gal+ cells in primary MEFs at consecutive cell 
passages (P < 0.0001, n = 3). Representative SA-gal images are also shown. (B) T3 increases expression of CDKN2A. To control for the level of pro-
tein in each sample, the same samples were run on a separate gel and detected for ACTB (-actin). (C) Percentage of SA-gal+ cells incubated with and 
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(KO) mice but not from THRB-deficient mice (Fig. S1 K). On 
the other hand, Thra KO MEFs showed a higher DNA damage 
after H2O2 treatment than those obtained from ThrbKO mice 
(Fig. S1 K), and both Thra and Thrb mRNAs were reduced 
after 6-d treatment with the DNA damaging agent camptothecin 
(Fig. S1 L). T3 and GC-1 also induced senescence and DNA 
damage in human hepatocyte HUH7 cells (Fig. 1 G), indicating 
the relevance of this hormonal action.
T3 did not induce senescence in MEFs obtained from 
Thra/ThrbKO mice that were spontaneously immortalized in 
culture. However, expression of THRB (but not THRA) in these 
cells restored the ability of T3 to induce proliferation arrest, 
senescence, and formation of DNA damage foci (Fig. 2, A–D). 
In ThrKO MEFs cultured with a serum substitute, transduction 
of THRB, but not THRA, increased senescence in the absence 
of ligand, and this action was further increased by T3 and 
GC-1 (Fig. 2 E). Therefore, the unliganded receptor has consti-
tutive effects on senescence when expressed at high intracellular 
concentrations. The percentage of cells undergoing senescence 
upon THRB expression was lower than in normal MEFs, but 
most of the immortal cell population became senescent when 
cells were previously exposed to a H2O2 shock (Fig. 2 F).
To determine the functional domains involved in T3- 
dependent induction of senescence, we used various THRB 
mutants (Fig. 3, A and B). Mutation C102G in the DNA-binding 
domain abolishes binding to the receptor recognition motifs. 
The AHT (Ala-His-Tyr) mutant is a triple substitution in the co-
repressor box that blocks binding of corepressors, and the muta-
tion E452Q is in the ligand-dependent transcriptional activation 
domain (AF-2) and abolishes the recruitment of coactivators. 
Only binding of T3 to wild-type THRB inhibited proliferation 
and induced DNA damage and senescence (Fig. 3, C–E). It is 
remarkable that THRB was able to induce senescence in this 
immortalized cell context in which H-RasV12 enhanced prolif-
eration rather than inducing OIS (Fig. 3, C and D).
Role of TP53 and ATM in T3-induced 
senescence and DNA damage
Because these proteins play a prominent role in replicative se-
nescence (Collado and Serrano, 2006) and genomic damage 
(Lee and Paull, 2005), we next examined the response to T3 in 
TP53- and ATM-deficient MEFs. Replicative senescence-resistant 
MEFs obtained from TP53KO mice (Harvey et al., 1993) also 
underwent partial cell cycle arrest and senescence upon incuba-
tion with T3 or GC-1 (Fig. 4, A and B) and showed increased 
DNA damage foci with colocalization of TP53BP1 and -H2AFX 
(Fig. 4 C). Other markers of genomic DNA damage or senescence, 
such as phosphorylation of H2AFX, CHEK1, and CHEK2 or 
the levels of H3F3A K9 3me (lysine 9 histone H3 trimethylation), 
were also increased by T3 to levels similar to those obtained in 
Gesing et al., 2012). In mammals, life span correlates with the 
metabolic rate (Mookerjee et al., 2010), which is controlled by 
the THs. Therefore, an increase of ROS production and oxida-
tive stress may be involved in the acceleration of aging by the 
THs. There is also increasing evidence that THRs play a role in 
cancer. THRs can inhibit oncogenic proliferation, transforma-
tion, tumor growth, tumor invasion, and formation of metastasis 
(García-Silva and Aranda, 2004; Aranda et al., 2009; García-
Silva et al., 2011). In addition, mutations or loss of expression 
of THRs are common events in some tumors (Aranda et al., 
2009; Kim and Cheng, 2013), suggesting that these receptors 
have tumor suppressor activity. Because THs accelerate aging 
and THRs suppress tumor growth, in this work, we have exam-
ined the possibility that they could induce cellular senescence 
and found that THRB, but not THRA, can mediate T3 (triiodo-
thyronine)-dependent premature senescence in cultured cells 
and in mice.
Results
T3 induces senescence and DNA damage  
in mouse embryonic fibroblasts (MEFs)
Incubation of MEFs with a physiological-relevant T3 concentra-
tion (5 nM) under 20% oxygen increases the amount of cells dis-
playing senescence-like features, such as senescence-associated 
-galactosidase (SA-gal) activity (Fig. 1 A), and increases the 
levels of CDKN2A (Fig. 1 B), demonstrating that the hormone 
induces premature senescence. Increased senescence by T3 is 
also observed under normoxic conditions (Fig. 1 C). MEFs ex-
press both THRA and THRB (Fig. S1 A), but THRB appears to 
mediate senescence because the THRB-specific ligand GC-1, 
with similar affinity as T3 for the receptor (Baxter et al., 2004), 
induces cell growth arrest and senescence to the same extent as 
the natural hormone (Fig. 1, D and E). These effects were strongly 
enhanced after transduction with a retroviral vector encoding 
THRB (Fig. S1, B and C).
Senescence is characterized by an activated DDR (Rodier 
et al., 2009), and incubation with T3 or GC-1 caused the appear-
ance of discrete DNA damage foci containing TP53BP1 (a marker 
of DSBs), increasing both the percentage of foci-containing 
cells and the number of foci per cell (Fig. 1 F and Fig. S1, D 
and E). In contrast with T3, DNA replication stress secondary 
to oncogenic H-RasV12–induced senescence (OIS) produced a 
more potent proliferation arrest and senescence and pannuclear 
TP53BP1 staining. Foci induced by T3 were similar, although 
less abundant, than those formed in response to  irradiation 
or to 600 µM H2O2 shock (Fig. S1, F–H). The effect of T3 on 
foci formation and senescence was quantitatively similar to that 
observed after treatment with 50 µM H2O2 (Fig. S1, I and J). 
T3 also increased TP53BP1 foci in MEFs from Thra knockout 
without T3 under normoxic conditions (3% O2). (D) Accumulated population doubling levels (PDLs) of MEFs cultured with serum replacement medium after 
two passages with and without T3 or GC-1 (5 nM; P < 0.0001, n = 3). (E) SA-gal images and percentage of SA-gal+ cells at the end of the treatment 
(P = 0.001, n = 3). (F) TP53BP1 foci after three passages. Percentages of cells with foci and the mean number of foci/cell are shown on the right (P = 
0.0018, n = 3). (G) PDLs, percentages of SA-gal+ cells, formation of TP53BP1 foci (P < 0,001, n = 3), and representative images of SA-gal and TP53BP1 
foci in HUH7 hepatocytes after one passage in serum replacement medium with and without T3 or GC-1. Bars: (A, E, and G, top) 20 µm; (F and G, bottom) 
10 µm. Results are presented as means ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Immortalized MEFs obtained from ATMKO mice (Callén 
et al., 2009) express THRB (Fig. 5 A), but these cells, which, 
under basal conditions, essentially do not exhibit TP53BP1 foci 
(Ward et al., 2003), were totally resistant to T3-mediated prolifera-
tion arrest or senescence. Furthermore, transduction of TP53KO 
cells subjected to H2O2 shock (Fig. 4 D). Complementation of 
TP53KO MEFs with an expression vector for TP53 slightly 
increased T3- and GC-1–induced senescence and DNA damage 
(Fig. 4 E), showing again that the tumor promoter is not essen-
tial for the hormonal response.
Figure 2. THRB mediates TH-induced senescence in MEFs. (A) THRB and THRA levels in immortalized MEFs from Thra/Thrb KO mice transduced with 
an empty vector or the receptors. (B) PDLs in cells incubated with and without T3 at three consecutive passages (P < 0.0001, n = 3). (C) Percentages of 
SA-gal+ cells at passage 3 (P < 0.0001, n = 3). (D) Percentages of cells with -H2AFX, TP53BP1 foci, and both markers (P < 0.0001, n = 3). (E) SA-gal+ 
MEFs after 3 d of treatment with T3 or GC-1 in a serum replacement medium (P < 0.0001, n = 3). Bars, 20 µm. (F) SA-gal in MEFs subjected to a 2-h 
shock with 600 µM H2O2 and incubated with or without T3 during 3 or 9 d postshock (d.p.s). P1, passage 1; P3, passage 3. (P < 0.0001, n = 3). Results 
are presented as means ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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DNA damage is not caused by defective 
DNA repair
We next examined the effect of T3 on repair of DNA damage in 
normal and TP53KO MEFs. For this purpose, cells were incu-
bated with T3 for 24 h before  irradiation, and TP53BP1 foci 
were evaluated at different times after irradiation. Irradiation 
induced massive foci formation, and the rate of recovery was 
similar in all groups, indicating that the increased genomic 
damage caused by T3 is not a consequence of reduced DNA 
repair (Fig. S2, A and B).
DNA damage is secondary to  
oxidative stress
We next tested whether oxidative stress could be responsible for 
the actions of T3 on genomic damage and senescence. As shown 
in Fig. 7 A, the levels of oxidized glutathione (a precise marker 
of the cellular oxidative status) were significantly increased by 
T3 in TP53KO MEFs. Because glutathione is an important sen-
sor of ROS in cells, we measured total cellular ROS levels, find-
ing that they were significantly increased as early as 3 h after 
incubation with T3, both in these cells as well as in wild-type 
MEFs with THRB enhanced T3-dependent cell growth arrest, 
senescence, and DNA damage, whereas ATMKO cells were 
unaffected (Fig. 5, B–E). However, transfection of ATM restored 
T3-dependent formation of DNA damage foci and senescence 
in ATMKO MEFs (Fig. 5 F), whereas incubation of wild-type 
primary MEFs with the ATM inhibitor KU-55933 abolished the 
effect of T3 and GC-1 (Fig. 5, G and H), indicating the key role 
of this kinase for TH-dependent senescence.
T3 induces formation of DNA  
strand breaks
The incorporation of deoxy-UTP (dUTP)–11-biotin by the ter-
minal deoxynucleotidyl transferase (TdT) enzyme was used to 
directly assess the presence of DNA breaks (Fig. 6). The per-
centage of cells showing breaks was significantly enhanced by 
T3 both in wild-type and TP53KO MEF cells but not in ATMKO 
cells, which presented a higher basal level of DNA breaks. Further-
more, T3 increased DNA breaks in primary MEFs from ThraKO 
mice, but not from ThrbKO animals, showing again that THRB 
mediates the effect of T3 on genomic damage.
Figure 3. Transcriptionally active THRB mediates TH-induced senescence and DNA damage in MEFs. (A) Schematic representation of THRB, showing posi-
tions of the mutations C120G, AHT, and E452Q. DBD, DNA-binding domain; LBD, ligand-binding domain. (B) Thra/ThrbKO MEFs were transduced with 
vectors for the different mutants or H-RasV12, and after selection, THRB was detected by Western blotting. TUBA1A was used as a loading control. Black 
lines indicate the removal of an intervening lane for presentation purposes. (C) PDLs, estimated after one, two, and three passages (P < 0.0001, n = 3). 
(D) Percentages of SA-gal+ cells after passage 3. (E) Percentage of cells having DNA damage foci determined from immunofluorescence of -H2AFX and 
TP53BP1 and merged images (P < 0.0001, n = 3). Results are presented as means ± SD. **, P < 0.01; ***, P < 0.001. WT, wild type.
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Figure 4. T3 induces DDR and senescence in TP53KO MEFs. (A) Accumulated PDLs of TP53KO MEFs in the presence and absence of T3 or GC-1 at 
three consecutive passages (P < 0.0001, n = 3). (B) SA-gal+ cells at passage 3 (P < 0.0001, n = 3). (C) -H2AFX and TP53BP1 immunofluorescences 
in TP53KO MEFs incubated with and without T3 during three passages. -H2AFX, TP53BP1, and merge images were quantitated, and the percentages 
of nuclei with foci and the distribution of cells with one, two, and more than three foci/nucleus are represented. (D) Western blot of DNA damage and 
heterochromatinization markers in TP53KO MEFs after three passages in the absence and presence of T3. Cells were also exposed to a 2-h shock with 
600 µM H2O2, washed, and cultured during three passages. (E) TP53 levels after transfection with an empty vector or a TP53 vector. (F) Percentages of 
SA-gal+ cells and formation of TP53BP1 foci in cells treated with T3 and GC-1. Bars: (B) 20 µm; (C and F) 10 µm. Results are presented as means ± SD. 
*, P < 0.05; ***, P < 0.001.
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Figure 5. THRB does not induce senescence in ATMKO MEFs. (A) THRB levels after transduction of an empty vector or the receptor in TP53- and ATM-deficient 
cells. TUBA1A was used as a loading control. (B) Accumulated PDLs in the presence and absence of T3 at three consecutive passages after selection 
(P < 0.0001, n = 3). (C) SA-gal+ cells at passage 3 (P < 0.0001, n = 3). (D) Representative merge images of double immunofluorescences of -H2AFX 
and TP53BP1 in TP53 and ATMKO MEFs incubated with and without T3 during three passages. (E) Confocal microscopy images of -H2AFX and TP53BP1 
in TP53KO MEFs. (F) ATM levels in ATMKO MEFs transfected with an empty vector or Flag-ATM. Percentages of SA-gal+ cells after one passage in T3 
and GC-1–treated cells, and representative images of TP53BP1 cells, indicating the percentages of Flag-positive cells with foci, are shown at the bottom. 
(G and H) Percentages of SA-gal+ cells (G) and TP53BP1 foci (H) in wild-type MEFs pretreated with the ATM inhibitor KU-55993 (10 µM) for 2 h and with 
T3 or GC-1 for one passage. Bars: (D) 10 µm; (E, F [bottom images], and H) 10 µM; (F [top images] and G) 20 µM. Results are presented as means ± SD. 
**, P < 0.01; ***, P < 0.001. inh., inhibitor.
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significantly enhanced after 3 h of T3 treatment (Fig. 7, E and F). 
No cross-reactivity of the secondary antibodies was observed 
(Fig. S3 B), and T3-dependent increase of -H2AFX/TP53BP1 
and 8-OH-dG/TP53BP1 foci was abolished by the antioxidant 
N-acetyl-l-cysteine (NAC; Fig. S3 C), confirming the oxidative 
nature of the DNA damage inflicted.
Because T3 induces ROS production and DNA damage, 
the hormone should also increase mitochondrial respiration. To 
demonstrate this, we measured oxygen consumption by high-
resolution respirometry. Incubation with T3 significantly en-
hanced routine cell respiration (Cr), reflecting aerobic metabolic 
activity under routine culture conditions, the oligomycin-inhibited 
leak rate of respiration after ATP synthase inhibition (CrO), and 
the maximal respiratory capacity (CrU), without altering non-
mitochondrial respiration (residual oxygen consumption [ROX]) 
in TP53KO MEFs and in wild-type MEFs. Therefore, T3 increases 
MEFs (Fig. 7 B). As expected, ATMKO cells present elevated 
basal ROS levels (Okuno et al., 2012), but in these cells, T3 did 
not induce a further increase (Fig. 7 B). Because the mitochon-
dria are the main source of free radicals, we also measured mito-
chondrial ROS levels with MitoSOX in TP53KO MEFs, observing 
enhanced mitochondrial ROS generation by T3 (Fig. 7 C). Fur-
thermore, mitochondrial ROS was increased by T3 in Thr-null 
MEFs after expression of THRB but not THRA (Fig. 7 D). The 
existence of oxidative stress in T3-treated cells was confirmed 
by the increased expression of antioxidant defense genes, which 
are induced in response to ROS with the role of protecting the 
cells against oxidative damage (Fig. S3 A).
An important DNA lesion secondary to oxidative stress is 
guanine oxidation with formation of 8-hydroxy-2-deoxyguano-
sine (8-OH-dG). We detected the presence of 8-OH-dG in nuclear 
foci colocalizing with TP53BP1, and the number of foci was 
Figure 6. T3 induces DNA breaks. (A) DNA strand breaks detected with the anti–biotin-HRP antibody in the presence or absence of T3 in the indicated 
MEF genotypes. Negative controls in the absence of TdT are also shown. Treatment with 600 µM H2O2 for 2 h was used as a positive control. Bars, 10 µm. 
(B) The percentages of cells with DNA strand breaks are shown. Results are presented as means ± SD. **, P < 0.01. WT, wild type.
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Figure 7. T3 induces oxidative DNA damage. (A) Relative oxidized glutathione (Rel. GSSG) levels in TP53KO MEFs incubated with or without T3 for 3 h. 
(B) Cellular ROS levels measured with H2DCFDA in TP53KO, ATMKO, and wild-type MEFs treated or not treated with T3 for 3 h (P = 0.0022, n = 3). Treat-
ment for 2 h with 1 mM H2O2 was used as a positive control. (C) Percentage of TP53KO MEFs positive for MitoSOX after incubation with T3 (P = 0.0001, 
n = 3). 0.1 mM paraquat (1 h) was used as a positive control. (D) Percentages of cells positive for oxidized MitoSOX in Thra/Thrb KO MEFs transduced 
with THRA or THRB and incubated with T3 during 3 h (P < 0.0001, n = 3). (E) Immunofluorescence of TP53BP1 and 8-OH-dG in MEFs treated for 24 h 
with and without T3. Merge and negative control images are also shown. (bottom) Confocal microscopy images showing colocalization of TP53BP1 and 
8-OH-dG in foci. Bars, 10 µm. (F) Quantification of TP53BP1/8-OH-dG foci. (G) High resolution respirometry of intact TP53KO, wild-type, and ATMKO 
MEFs incubated with or without T3. Cellular oxygen flow (pmol/s × 106 cells) was measured under routine conditions (Cr; P < 0.0001, n = 3), inhibition 
by oligomycin (CrO; P = 0.0011, n = 3), uncoupling to maximum flux (CrU; P < 0.0001, n = 3), and nonmitochondrial respiration (ROX). Results are 
presented as means ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001. WT, wild type.
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Figure 8. T3 enhances mitochondrial gene expression in MEFs. (A and B) mRNA levels of representative genes of the respiratory chain in TP53KO (A) and 
ATMKO (B) MEFs incubated with T3 for 1 h. Results are means ± SD (P ≤ 0.0044, n = 3) and are expressed relative to the values obtained in the untreated 
cells. (B) mRNA levels of TFAM and NRF1 analyzed at 0, 1, 3, and 24 h of T3 treatment (P < 0.0001, n = 3). (C) Western blot of NRF1 in TP53KO and 
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that, as expected, the amount of coimmunoprecipitated NRF1 is 
higher in T3-treated cells that express higher levels of this factor. 
The existence of a direct interaction between THRB and NRF1 
was further demonstrated in a GST pull-down assay (Fig. 8 G).
NRF1 is required for T3-dependent DNA damage because 
its depletion with siRNA abolished formation of -H2AFX/
TP53BP1 foci by the hormone (Fig. 9, A and B). NRF1 under-
goes posttranslational modifications that lead to increased bind-
ing to its DNA motif (Gugneja and Scarpulla, 1997). A possible 
mediator is PRKAA (AMP-activated protein kinase), a direct 
ATM target (Alexander et al., 2010), which plays a key role in 
mitochondrial biogenesis (Fu et al., 2008) and can be regulated 
by the TH (Yamauchi et al., 2008; López et al., 2010). We found 
a rapid phosphorylation of PRKAA by T3, and this response 
was markedly blunted in ATM-deficient MEFs (Fig. 9 C). Pre-
incubation of cells with the PRKAA inhibitor compound C or 
with the ATM inhibitor KU-55993 abolished T3-dependent 
increase of NRF1 (Fig. 9, D and E), proving the central role of 
PRKAA and ATM in NFR1 induction by T3. ATM and PRKAA 
activation was also an essential step for the development of oxi-
dative DNA damage because both inhibitors blocked formation 
of 8-OH-dG/TP53BP1 foci by T3 (Fig. 9, F and G). Finally, 
transduction of MEFs with an adenoviral vector encoding a 
dominant-negative form of PRKAA abolished the effects of T3 
on PRKAA phosphorylation, induction of NRF1 and formation 
of DNA damage foci (Fig. 9, H and I), confirming that PRKAA 
activation plays an essential role on mitochondrial activation, 
ROS generation, and formation of DNA DSBs by the hormone.
THs induce senescence and oxidative  
DNA damage in vivo
We next examined the effect of TH treatment on senescence and 
DNA damage in vivo. For this, we treated wild-type, ThraKO, 
and ThrbKO mice with THs for 2 wk, and DNA damage was 
evaluated in the liver and kidney, which express preferentially 
THRB, and in the heart, which expresses high THRA levels 
(Fig. S4 A). Hyperthyroidism was confirmed by elevated ex-
pression of Deiodinase 1 mRNA, a sensitive marker of TH ac-
tion (Fig. S4 B; Zavacki et al., 2005). Senescence was negligible 
in livers of young euthyroid mice, but hyperthyroid livers from 
wild-type mice showed a significant number of senescent cells 
and an increased number of cells expressing high CDKN2A 
levels (Fig. 10 A). Similar results were obtained in ThraKO 
mice, but not in ThrbKO mice, confirming in vivo that THRB 
is the receptor isoform mediating these effects of THs. T3 also 
induced senescence and DNA damage in normal primary hepato-
cyte cultures (Fig. S5 A). -H2AFX foci were observed in eu-
thyroid livers of all groups, and hyperthyroidism significantly 
increased the percentage of cells bearing -H2AFX foci as well 
mitochondrial respiration, augmenting electron flux through the 
respiratory chain and consequently the production of superox-
ide anion, the most abundant mitochondrial ROS. However, in 
agreement with the high levels of ROS and DNA breaks found 
in ATMKO MEFs, these cells showed high basal levels of oxy-
gen consumption, which were not increased by T3 (Fig. 7 G).
PRKAA and ATM are essential for 
mitochondrial activation and induction  
of DNA damage by T3
Increased electron flux should be a consequence of increased 
expression of respiratory chain components. Therefore, we next 
analyzed the effect of T3 on transcript levels of representative 
genes of the respiratory chain encoded by nuclear (Uqcrfs1, 
Rac1, Sco1, and Cox10) or mitochondrial DNA (Mt-cyb and 
Mt-co1). Remarkably, 1 h of incubation with T3 induced an early 
expression of all these genes in TP53KO but not in ATMKO 
MEFs (Fig. 8 A).
NRF1 (nuclear respiratory factor 1) and TFAM (transcrip-
tion factor A, mitochondrial) are the major transcription factors 
responsible for mitochondrial gene expression (Scarpulla, 2002). 
mRNA levels of Tfam, which is essential for transcription of 
genes of the respiratory chain, were rapidly induced by T3 
(Fig. 8 B). Tfam transcription in turn depends on NRF1 binding 
to its promoter (Virbasius and Scarpulla, 1994). NRF1 tran-
scripts were not induced by T3 in MEFs, but a rapid increase of 
NRF1 protein levels was found after T3 incubation, showing the 
existence of a rapid posttranscriptional regulation. NRF1 induc-
tion was also ATM dependent because no changes were found 
in ATMKO MEFs (Fig. 8 C).
We next performed chromatin immunoprecipitation (ChIP) 
assays with four overlapping fragments of the Tfam promoter to 
examine whether transcriptional stimulation of the Tfam gene 
by T3 involves increased NFR1 binding (Fig. 8 D). Incubation 
with T3 for 1 h caused an enrichment of histone 3 acetylation, 
a mark of transcriptional activation, mainly in the areas closer 
to the transcription start site. In addition, T3 induced NRF1 re-
cruitment, particularly to the more proximal promoter fragment, 
and THRB was concomitantly recruited in a hormone-dependent 
manner. Neither histone acetylation nor NRF1 or THRB recruit-
ment were found in ATM-deficient MEFs, emphasizing its im-
portance for T3-mediated stimulation of mitochondrial gene 
expression. These results were extensive to other NRF1-dependent 
genes, such as Uqcrfs1, in which enrichment of promoter his-
tone 3 acetylation and NRF1 and THRB recruitment in response 
to T3 were only observed in the presence of ATM (Fig. 8 E). T3-
dependent NRF1 recruitment to the promoter could involve a 
direct interaction of this transcription factor with THRB, as sug-
gested by coimmunoprecipitation experiments. Fig. 8 F shows 
ATMKO MEFs incubated with T3 for the indicated times. TUBA1A was used as a loading control. Densitometry (NRF1/TUBA1A) in arbitrary units (a.u.) is 
shown on the right. (D) ChIP assays with the indicated antibodies. The depicted areas of the Tfam promoter were amplified in TP53KO cells, and the indi-
cated areas were amplified in ATMKO MEFs. (E) ChIP assays in TP53KO and ATMKO MEFs with the proximal Uqcrfs1 promoter. Cells were treated with 
and without T3 for 1 h. Ac., acetylated. (F) Coimmunoprecipitation of THRB and NFR1. TP53KO MEFs were labeled in [35S]methionine/cysteine-containing 
medium for 16 h in the presence or absence of T3 and immunoprecipitated with control IgGs, THRB, or NRF1 antibodies as indicated. IP, immunoprecipi-
tation. (G) GST pull-downs performed with cellular extracts of untreated and T3-treated cells and GST or GST-THRB. The inputs (10%) of the total are also 
shown. Results are presented as means ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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Figure 9. PKRAA and ATM activation is required 
for T3-dependent NRF1 induction and oxidative DNA 
damage. (A) Western blot of NRF1 in TP53KO MEFs 
treated with T3 for 3 h after transfection with control or 
NRF1 siRNAs 48 h before. (B) Percentage of nuclei with 
-H2AFX/TP53BP1 foci in these cells. (C) Phosphory-
lated and total PRKAA evaluated by Western blotting 
in TP53KO and ATMKO MEFs incubated with T3 for 
times ranging between 0 and 60 min. Densitometries 
(P-PRKAA/PRKAA) in arbitrary units (a.u.) are shown 
on the right. (D) NRF1 levels in TP53KO and wild-type 
MEFs preincubated for 2 h with 20 µM compound C be-
fore treatment with T3 for 3 h. Wt, wild type. (E) NRF1 
in TP53KO cells preincubated with 10 µM KU-55993. 
TUBA1A was used as a loading control. inh., inhibitor. 
(F) TP53BP1/8-OH-dG immunofluorescences in cells 
treated as in D and E. Bars, 10 µm. (G) Quantifica-
tion of TP53BP1/8-OH-dG foci in the same groups (P < 
0.0001, n = 3). (H) Cells were infected with adenovi-
rus expressing a dominant-negative (dn) PRKAA. After 
24 h, cells were treated with T3 for 3 h, and the levels 
of NRF1, P-PRKAA, and total PRKAA were analyzed by 
Western blotting. Mock-infected cells were used as con-
trols. (I) Percentages of nuclei bearing -H2AFX/TP53BP1 
foci in cells expressing dominant-negative PRKAA. Re-
sults are presented as means ± SD. **, P < 0.01; ***, 
P < 0.001.
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Figure 10. THRB mediates induction of senescence and DNA damage in the hyperthyroid mice liver. (A) Detection of SA-gal and CDKN2A in livers from 
wild-type, ThraKO, and ThrbKO mice (six mice for each condition). Nuclear Fast Red was used as the counterstaining. (B) -H2AFX immunohistochemistry 
in the livers. Negative controls (without primary antibody) are also shown. Some foci are signaled with arrowheads. (C) Percentages of cells with foci and 
the mean number of foci/nucleus. (D) Detection of 8-OH-dG by immunohistochemistry in livers of euthyroid and hyperthyroid (hyperth.) wild-type mice. 
A negative control of a hyperthyroid liver is also shown. Representative cells (dotted squares) are shown as insets. Percentages of cells positive for 
8-OH-dG is shown on the right. Bars: (A, B, and D, main images) 10 µm; (D, insets) 10 µM. wt, wild type. Results are presented as means ± SD. **, P < 0.01; 
***, P < 0.001.
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converting 1–3% of oxygen molecules into superoxide (Chance 
et al., 1979). It has been known for decades that the THs regu-
late basal metabolic rate, heat production, and oxygen consump-
tion (Tata et al., 1962; Oppenheimer et al., 1987), and therefore, 
they can increase ROS generation and cause oxidative stress 
(Videla, 2010). Using high-resolution respirometry, we could 
demonstrate for the first time that T3 induces an evident in-
crease of oxygen consumption at different respiratory states in 
intact cells. This augmented mitochondrial respiration would 
lead to enhanced electron leak and ROS generation.
T3 stimulates expression of genes of the respiratory chain, 
which could lead to increased oxygen consumption. T3 medi-
ates a rapid and important increase of Tfam, a transcription 
factor essential for mitochondrial gene transcription (Larsson 
et al., 1998), and this activation may play an important role in 
the mitochondrial response to the hormone. Tfam transcription 
depends critically on binding of nuclear respiratory factors to its 
promoter (Virbasius and Scarpulla, 1994), and we observed an 
early posttranscriptional induction of NRF1 levels by T3. Be-
sides Tfam, many genes encoding subunits of the five respira-
tory complexes contain functional NRF1 binding sites within 
their promoters. We could demonstrate that the mechanism of 
stimulation of mitochondrial activity by T3 reflects a rapid 
chromatin remodeling, detected by increased histone acetyla-
tion and recruitment of NRF1 and THRB to the promoter region 
of genes such as Tfam or the respiratory gene Uqcfrs1. It is 
known that NRF1 phosphorylation enhances DNA binding 
(Gugneja and Scarpulla, 1997). PRKAA has been shown to 
activate NRF1 expression, increasing binding to DNA, and to 
stimulate mitochondrial biogenesis (Bergeron et al., 2001), and 
we demonstrated here the essential role of this kinase on mito-
chondrial T3 actions because the hormone induces a very rapid 
activation of PRKAA, and this activation is required for NRF1 
induction and for the consequent development of oxidative 
DNA damage.
ATM plays a pivotal role on the detection of the genomic 
damage and DDR (Harper and Elledge, 2007). We observed 
here that T3 was unable to induce proliferation arrest and senes-
cence in the absence of ATM, even when THRB is expressed 
at high levels, whereas reexpression of the kinase restored the 
actions of T3. ATM plays a crucial role on the activation of the 
mitochondrial function by T3 in MEFs. Thus, the hormone 
does not induce NRF1 recruitment to mitochondrial promoters 
in the absence of this kinase, and subsequent transcription of 
respiratory chain components or TFAM is not observed. This 
correlates with the lack of effect of T3 on ROS generation and 
oxidative DNA damage in ATMKO MEFs. ATM phosphory-
lates the  subunit of PRKAA (Suzuki et al., 2004; Sun et al., 
2007; Alexander et al., 2010), and stimulation of PRKAA phos-
phorylation by T3 is markedly reduced in ATM-deficient MEFs. 
Therefore, ATM-dependent PRKAA signaling appears to be 
needed for the effect of T3 on mitochondrial activity, suggesting 
that this kinase not only directs DDR but could also be required 
at the first steps leading to generation of DSBs by the recep-
tor. It is also possible that the high basal levels of ROS found 
in ATMKO cells have made the cells unresponsive to a further 
increase of ROS by T3, and as a consequence, the hormone 
as the number of foci per cell in wild-type and ThraKO mice but 
not in ThrbKO mice (Fig. 10, B and C). Furthermore, immuno-
histochemical staining of 8-OH-dG showed that hyperthyroid 
livers exhibited a significantly larger number of nuclei with oxi-
dative lesions, detected either as discrete foci or pannuclear 
staining (Fig. 10 D), and double immunofluorescences in the 
livers from euthyroid and hyperthyroid mice demonstrated co-
localization of -H2AFX and TP53BP1 with 8-OH-dG in foci 
(Fig. S5 B).
-H2AFX foci were also observed in euthyroid kidneys 
in all genotypes, although in a lower number than in livers, and 
hyperthyroidism increased the number of foci in wild-type and 
THRA-deficient mice but not in mice lacking THRB. However, 
no senescent cells were found in this organ. In contrast with the 
THRB target tissues, no detectable increase of DNA damage 
was observed in hyperthyroid hearts (Fig. S4 C), reinforcing the 
idea that this effect of T3 is observed in THRB but not THRA 
target organs.
Discussion
In this study, we define THRB as a novel inductor of cellular se-
nescence and DNA damage. T3 induces senescence in MEFs and 
hepatocytes, and this action is mediated by THRB. CDKN2A 
and TP53 are major components of replicative and OIS (Collado 
and Serrano, 2006), but surprisingly, the effect of T3 appears to 
be largely independent of TP53 because the hormone can arrest 
proliferation and induce partial senescence in TP53-deficient 
immortal MEFs. A potential mechanism by which THRB could 
bypass the lack of TP53 on senescence is that T3 increased 
CDKN2A, suggesting that, as in the case of stress-induced senes-
cence (Serrano et al., 1996), the hormone could work mainly 
through the activation of this cyclin kinase inhibitor.
T3 generates DNA damage, which is crucial in the induc-
tion of cellular senescence (d’Adda di Fagagna et al., 2003; Rodier 
et al., 2009). DDR involves the recruitment of -H2AFX and 
TP53BP1, a marker of DSBs (Rogakou et al., 1999; Schultz 
et al., 2000; Abraham, 2002), at the sites of DNA breakage. 
T3 mediates DSB generation that has an oxidative origin because 
(a) the hormone enhances the appearance of 8-OH-dG, a biomarker 
of oxidative DNA damage, (b) there is a strong cofocalization 
of 8-OH-dG with TP53BP1, showing the presence of oxidized 
DNA at the sites with DSBs, and (c) the antioxidant NAC pre-
vents formation of foci containing 8-OH-dG and the DNA dam-
age marker by T3.
T3 appears to cause persistent genomic damage because 
an increased number of nuclear DNA damage foci was observed 
at passage 3, i.e., at 9 d of treatment. However, enhanced forma-
tion of foci containing DSBs and oxidized DNA was detected 
after 3 h of T3 treatment, showing that this is an early hormonal 
action. The rapid appearance of genomic damage is compatible 
with the rapid increase of oxidized glutathione and mitochon-
drial ROS generation. ROS can induce base oxidation, abasic 
sites, and even both single and double DNA breaks (Wyman 
and Kanaar, 2006).
ROS are generated as a byproduct of mitochondrial respira-
tion because electrons leak from the electron transport chain, 
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damage observed in liver and kidney after TH administration 
to mice could be involved in tissue damage observed in hyper-
thyroid conditions and supports the clinical use of antioxidant 
drugs to prevent these abnormalities (Leo et al., 2012).
Materials and methods
Mice and animal care
Wild-type mice and mice lacking the TH-binding isoforms THRA1 or THRB 
(ThraKO and ThrbKO, respectively), provided by B. Vennström (Karolinska 
Institute, Stockholm, Sweden), were made hyperthyroid by adding thyrox-
ine (95 ng/g of mice) and T3 (25 ng/g of mice) to the drinking water for 
2 wk. Experiments were performed twice in 2- and 6-mo-old mice. All experi-
ments were performed following the regulations of the Consejo Superior de 
Investigaciones Científicas for animal care and handling (RD 53/2013).
Transfections, cell proliferation, and SA-gal analysis
Cultures of MEFs were obtained at 13.5 d postcoitum. Wild-type, ThraKO, 
and ThrbKO MEFs were incubated ≥24 h before the experiments in me-
dium containing 10% TH-depleted bovine fetal serum by treatment with 
resin AG-1-X8 (Bio-Rad Laboratories) or in serum-free medium containing 
Serum replacement-1 (Sigma-Aldrich) and 10 ng/ml human FGF basic. 
MEFs were normally grown with 20% O2, except for the experiment shown 
in Fig. 1 C, which was performed under normoxic conditions (3% O2). 
Cells were treated with T3 or with GC-1 (provided by T.S. Scanlan, Ore-
gon Health and Science University, Portland, OR), as indicated in the cor-
responding figures. Immortalized MEFs from Thra/Thra double-KO mice 
provided by J. Samarut (Ecole Normale Supérieure de Lyon, Lyon, France), 
TP53KO mice (M. Serrano, Centro Nacional de Investigaciones Oncológi-
cas, Madrid, Spain), and ATMKO mice (E. Callen, National Institutes of 
Health, Bethesda, MD) were also used. Primary hepatocytes were a gift 
from A.M. Valverde (Instituto de Investigaciones Biomédicas, Madrid, 
Spain). pLPCX-THRB, pLPCX-THRA, the C102G, AHT and E457Q THRB 
mutants (García-Silva et al., 2011), or the empty vector was used to infect 
MEFs by retroviral transduction. MEFs were also transduced with 
pWLZ-Ha-Rasval12 or pWLZ and selected with hygromycin for 5 d (García-
Silva and Aranda, 2004). Transfections with control siRNA (D-001210-01-
05; Thermo Fisher Scientific) and NRF1 siRNA (sc-43576; Santa Cruz 
Biotechnology, Inc.) were performed with Lipofectamine 2000 reagent (In-
vitrogen). Complementation of TP53KO and ATMKO MEFs was performed 
by transfection of pcDNA-TP53 or Flag-ATM vectors by the TransIT-TKO 
transfection method (Mirus Bio LLC). Growth curves were generated follow-
ing the 3T3 protocol (Todaro and Green, 1963). Accumulated population 
doubling levels (PDLs) were calculated as PDL = log(Nf/N0) × 3.33, in 
which N0 is the number of inoculated cells, and Nf is the final number of 
cells obtained after 3 d. SA-gal activity was determined as reported by 
Dimri et al. (1995) or with the Senescence Detection Kit (BioVision, Inc.). 
Micrographs were taken in a microscope (TS100F; Nikon) with a digital 
camera (DS-L1; Nikon), and the percentage of -galactosidase+ MEFs was 
calculated after counting >200 cells.
Protein and RNA analysis
Western analysis, RNA extraction, and quantitative real-time PCR were 
performed as previously described (García-Silva et al., 2011) using the 
antibodies and primers listed under Tables S1 and S2.
Metabolic labeling and coimmunoprecipitation
Cells growing in p100 plates were incubated for 2 h in methionine/cysteine-
free medium (Gibco) and labeled with 70 µCi/ml [35S]methionine/cysteine 
(PerkinElmer) for 16 h in medium containing glutamine and 10% dialyzed 
FBS in the presence or absence of 5 nM T3. The cells were washed with 
ice-cold PBS and lysed in triple-detergent lysis buffer (50 mM Tris-HCl, 
pH 8.0, 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 1% NP-40, 0.5% 
sodium deoxycholate, 1 mM PMSF, 2 µg/ml pepstatin, 2 µg/ml aprotinin, 
2 µg/ml leupeptin, and phosphatase inhibitors cocktail 2 and 3 [Sigma-
Aldrich]). Lysates were precleared for 1 h/4°C with 50% slurry of pro-
tein A–Sepharose (CL-4B), reconstituted with single-detergent lysis buffer 
(50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.02% sodium azide, 1% NP-40, 
1 mM PMSF, 2 µg/ml pepstatin, 2 µg/ml aprotinin, 2 µg/ml leupeptin, and 
phosphatase inhibitors cocktail 2 and 3). 30 × 106 cpm per lysate and 
2 µg antibody were incubated overnight at 4°C in a rotatory shaker. Immuno-
precipitation complexes were incubated with 100 µl of 50% slurry of pro-
tein A–Sepharose beads for 1 h at 4°C and recovered by centrifugation at 
would not induce DNA damage and senescence in these cells. 
In summary, these results suggest a model in which T3 binding 
to THRB induces a rapid nongenomic activation of PRKAA, in 
an ATM-dependent manner. This leads to NRF1 activation and 
recruitment, together with the receptor, to the promoters of key 
mitochondrial genes, which are essential to increase oxygen 
consumption. Increased respiration induces the production of 
mitochondrial ROS, which in turn causes oxidative stress and 
DSBs, triggering a persistent DDR that ultimately leads to pre-
mature senescence of susceptible cells.
The physiological importance of our findings is reinforced 
by the observation that administration of THs induces prema-
ture senescence in livers of young mice. This action is mediated 
by THRB because hyperthyroid livers from Thrb-null mice do 
not display senescent cells. Furthermore, these animals do not 
show enhanced oxidative DNA damage in contrast with the 
findings in wild-type and Thra-null mice. It was unexpected 
that oxidative DNA lesions that can be rapidly repaired by base 
excision repair generated DSBs in terminally differentiated 
nondividing hepatocytes. It is possible that other mechanisms, 
for example nonhomologous end joining could operate because 
very recent studies describe that TP53BP1 (in cooperation with 
RIF1) can block DSB resection and promotes nonhomologous 
end joining in G1 phase (Callén et al., 2013; Escribano-Díaz 
et al., 2013; Zimmermann et al., 2013).
In the kidneys, another THRB target tissue, TH treatment 
also induces formation of DNA damage foci in wild-type and 
ThraKO mice, although in this case, senescent cells are not ob-
served at this age. This might be caused by the lower number of 
DNA damage foci observed in this organ. In contrast to the 
damage observed in the liver and kidney, hyperthyroidism did 
not induce DNA damage in the heart, a THRA target tissue 
(Pascual and Aranda, 2013).
Our findings provide a mechanism for integrating the 
well-known metabolic effects of THs with other important pro-
cesses, such as cellular senescence. Cellular senescence plays 
an important role in aging and in the control of life span (Vijg 
and Campisi, 2008; Baker et al., 2011), and our results can shed 
light onto the mechanisms by which thyroidal status affects lon-
gevity. Hormonal regulation has been recently linked to DNA 
damage. Thus, mice with defects in DNA repair pathways show 
suppression of genes such as deiodinase 1/2 or THRs with an 
important role in somatotroph, lactotroph, and thyrotroph axes 
(Niedernhofer et al., 2006; van der Pluijm et al., 2007; Garinis 
et al., 2009). The current notion is that such responses are adap-
tive and could improve animal survival. Our results strengthen 
this hypothesis and show that THR expression is altered in MEFs 
exposed to genotoxic agents. In addition, cellular senescence 
also represents an important barrier against tumor develop-
ment in vivo (Collado and Serrano, 2010). Because THRB re-
presses cellular transformation and tumor progression, induction 
of senescence could be a critical component of the initial tumor-
suppressing mechanism of this receptor. Finally, it is known that 
liver damage is a relatively common clinical characteristic in 
hyperthyroid patients (Habershon, 1874; Malik and Hodgson, 
2002), and tissue damage appears after TH administration in 
rats (Upadhyay et al., 2004). The occurrence of oxidative DNA 
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Triton X-100 and 0.1% sodium citrate. Preparations were washed with PBS 
and washing solution (PBS/0.25% BSA/0.1% Tween 20), blocked for 
30 min with blocking solution (washing solution, 2.5% BSA, and 5% normal 
serum), and incubated overnight with -H2AFX, TP53BP1, and 8-OH-dG 
antibodies (Table S1). Preparations were then washed with washing solu-
tion and incubated with secondary antibodies for 1 h at RT. Nuclei were 
counterstained with DAPI, and samples were mounted with ProLong 
(Molecular Probes). Cell images were captured with a fluorescence micros-
copy (E90i) equipped with a camera (DS-Q1Mc; Nikon) and NES Elements 
software. DNA damage foci were counted from >200 cells for each exper-
imental condition. Analysis of cofocalization was performed with a confo-
cal microscope (LSM 710; Carl Zeiss; 63×/1.4 NA lens Plan Apochromat), 
using Argon (488 nm), HeNe (543 nm), and diode violet (405 nm) lasers. 
Images were obtained with software (ZEN 2009; Carl Zeiss).
Immunohistochemistry, SA-gal detection, and multiple antigen 
fluorescent labeling
Mice liver, kidney, and heart samples were either fixed in 4% buffered for-
malin and embedded in paraffin wax or flash frozen with liquid N2 and 
embedded in O.C.T. (Tissue-Tek). For -H2AFX, immunohistochemistry was 
performed on 4-µm deparaffinized, rehydrated sections. Antigen retrieval 
was performed in a Microwave Tender Cooker, and endogenous peroxi-
dase activity was inhibited with 0.3% H2O2 in methanol. Permeabilization, 
blocking, and overnight incubation with the antibody were performed with the 
Vectastain ABC kits (Vector Laboratories). For 8-OH-dG staining, 10-µm-thick 
flash-frozen sections were fixed with 1% PFA, washed, blocked with 
1% BSA, and incubated with the antibody for 3 h. For CDKN2A staining, 
frozen sections were fixed 2 min with ethanol, gradually rehydrated, and 
incubated overnight at RT with the antibody. Revealing, counterstaining, 
and mounting were performed as described in the previous section. To detect 
SA-gal, 10-µm-thick flash-frozen liver sections were used. Sections were 
fixed for 2 min with ethanol and gradually rehydrated before being incu-
bated overnight at 37°C with the SA-gal reaction mixture. The sections 
were counterstained with Nuclear Fast Red and mounted. For multiple anti-
gen labeling of liver sections, we used the double-immunofluorescent labeling 
protocol and reagents provided by Vector Laboratories (A-2011, A-2016, 
SP-2001, BA-1400, BA-5000, and Vectastain ABC kits). Sequential incu-
bations of the antibodies were overnight and 3 h at RT for the first and sec-
ond antibody, respectively. Nuclei staining, mounting, and microscopy 
acquisition were performed as for the indirect immunofluorescence.
Statistical analysis
Statistical significance of data were determined by applying a two-tailed 
Student’s t test or analysis of variance followed by the Newman–Keuls or 
Bonferroni test for experiments with more than two experimental groups. P < 
0.05 is considered significant. Significance of analysis of variance posttest 
or the Student’s t test is indicated in the figures as *, P < 0.05; **, P < 
0.01; and ***, P < 0.001. Statistics were calculated with the Prism 5 soft-
ware (GraphPad Software). All results are presented in the figures as 
means ± SD.
Online supplemental material
Fig. S1 shows that THRB overexpression increases senescence and DNA 
damage in MEFs and compares the effect of THRB, H2O2, and H-RasV12. 
Fig. S2 illustrates that the increased DNA damage observed after T3 treat-
ment is not secondary to inhibition of DNA repair. Fig. S3 demonstrates 
that antioxidant response genes are induced by T3, controls of secondary 
antibodies, and that NAC prevents T3-induced oxidative DNA damage. 
Fig. S4 shows expression levels of THRA and THRB in mouse tissues and 
proves that THs induce DNA damage in THRB, but not THRA, target tissues. 
Fig. S5 shows induction of senescence by T3 in primary mice hepatocytes 
and colocalization of DNA damage markers in the liver. Table S1 contains 
a list of antibodies used in this study. Table S2 contains a list of primers 
used for quantitative PCR. Table S3 contains a list of primers used for ChIP 
assays. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201305084/DC1.
We thank M. Sánchez-Prieto, C. González Páramos, and the core facilities of 
the Instituto de Investigaciones Biomédicas for technical help and O. Fernandez-
Capetillo for advice.
This work was supported by grants from Ministerio de Economía y 
Competitividad (BFU2011-28958 to A. Aranda and SAF2009-11150 to A. 
Pascual), from the Instituto de Salud Carlos III (RD012/0036/0030 to A. 
Aranda; and PI 07/0167 and PI 10/0703 to R. Garesse), from the Comuni-
dad de Madrid (S2011/BMD-2328 TIRONET to A. Aranda), and European 
Union grant project CRESCENDO (FP6-018652 to A. Aranda and L.M. Sachs).
The authors have no conflicting financial interests.
2,000 rpm. The complexes were washed four times with single-detergent 
lysis buffer and resuspended in 50 µl Laemmli buffer. The samples were 
boiled and loaded on 8% SDS-PAGE. Gels were fixed, treated with 
EN3HANCE (PerkinElmer), and exposed to x-ray films under standard 
conditions. The antibodies used were normal IgGs, THRB (Rockland Im-
munochemicals, Inc.), and NRF1 (Table S1).
GST pull-down assays
GST-0 and GST-THRB fusion proteins were expressed in the bacterial strain 
BL21 (DE3). They were grown at 37°C in 2× YT (16 g/liter tryptone, yeast 
extract, and 5 g/liter NaCl, pH 7) until the absorbance reached 0.6. 
Then, the induction was performed at 30°C for 3 h with 0.4 mM isopropyl- 
1-thio--d-galactopyranoside. The expression of correctly sized proteins was 
monitored by SDS-PAGE as described previously. Cells were treated or not 
treated with T3 for 16 h and lysed in triple-detergent lysis buffer. 500 µg/
reaction of lysate was precleared for 1 h at 4°C with 50 µl of 50% slurry 
of glutathione-Sepharose (CL-4B; GE Healthcare) reconstituted with single-
detergent lysis. Lysates were incubated with GST fusion proteins overnight at 
4°C and washed three times with single-detergent lysis buffer. Protein com-
plexes were eluted in Laemmli buffer and loaded on 8% SDS-PAGE. Western 
blotting was performed with THRB and NRF1 antibodies (Table S1).
ROS analysis
Cellular ROS levels were assessed with 20 µM H2DCFDA (2,7-dichlorodi-
hydrofluorescein diacetate; Sigma-Aldrich). Measurements were made in a 
microplate fluorometer every 2 min for 1 h at 37°C with 485/20-nm and 
528/20-nm filters. Analysis of mitochondrial ROS was performed as previ-
ously described (Mukhopadhyay et al., 2007) using MitoSOX (Invitrogen) 
and flow cytometry.
Oxidized glutathione analysis
Oxidized glutathione measurement was performed with the Glutathione 
Assay Kit II (EMD Millipore).
High resolution respirometry
Respiration in intact cells was measured at 37°C by high resolution respi-
rometry using Oxygragh-2k (Oroboros Instruments), and the DatLab4 soft-
ware was used (Oroboros Instruments; Hütter et al., 2006). The protocol 
includes the determination in a sequential manner of the aerobic metabolic 
activity under routine culture conditions with the physiological substrates in 
culture medium (Cr), the oligomycin-inhibited leak rate of respiration after 
inhibition of ATP synthase with 2 µg/ml oligomycin (CrO), the maximum 
respiratory capacity of uncoupled mitochondria in nonpermeabilized cells 
(CrU), obtained by sequential addition of 0.5-µM boluses of trifluorocar-
bonylcyanide phenylhydrazone, and ROX, reflecting nonmitochondrial 
respiration, obtained after inhibition of complex I with 0.1 µM rotenone 
and complex III with 2.5 µM antimycin A. ROX was subtracted to calculate 
Cr, CrO, and CrU oxygen fluxes.
ChIP assays
Cells were plated in 150-mm dishes and the next day treated with 2.5 µM 
-amanitin in serum-free medium for 2.5 h. Cells were then washed and 
treated with 5 nM T3 for 1 h, fixed and lysed following specifications of the 
ChIP Assay Kit (EMD Millipore), and sonicated in a Bioruptor (UCD-200TM; 
Diagenode). In each immunoprecipitation, 2–3 × 106 cells and the amount 
of antibodies listed in the Table S1 were used. DNA was purified, precipi-
tated, and amplified with the primers listed in Table S3.
DNA breaks labeling
To detect DNA breaks, we developed a method based in dUTP incorpora-
tion by TdT and posterior detection by immunocytochemistry. Cells were 
fixed with 2% PFA for 10 min and then permeabilized with permeabiliza-
tion buffer containing 0.1% Triton X-100 and 0.1% sodium citrate. After 
washing with PBS for 5 min, they were incubated overnight at 37°C with 
a 50-µl reaction mixture containing 15 U of the TdT enzyme (Promega) 
and 200 µM dUTP-11-biotin (Thermo Fisher Scientific). Cells were washed 
again and then incubated for 20 min with 1% PBS-BSA and 1 h at RT 
with antibiotin HRP-conjugated antibody (Table S1) diluted in 1% PBS-BSA. 
Revealing was performed following specifications of the DAB Substrate Kit 
(Vector Laboratories). Nuclei were counterstained with Nuclear Fast Red 
(Sigma-Aldrich), and preparations were mounted with mounting medium 
(DePeX; Serva). Micrographs were taken with a microscope (E90i; Nikon) 
with a camera (DS-Fi1) and NES Elements software (Nikon).
Indirect immunofluorescence microscopy
Cells growing in 8-well chambers (Thermo Fisher Scientific) were fixed in 
2% PFA for 10 min at RT, washed with PBS, and permeabilized with 0.1% 
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